Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

8.160 -0.050 (-0.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
 
Via Benzinga
Topics Stocks
Prothena Catapults, Flashing A Bullish Sign, On Promise In Parkinson's Disease
The drug technically missed the study's primary goal. But there's still promise it could work in specific patients. 
Via Investor's Business Daily
Roche-Prothena Partnered Mid-Stage Parkinson's Trial Misses Primary Endpoint, But Cling On Signs Of Clinical Benefits
Prothena and Roche report Phase 2b PADOVA results on prasinezumab in Parkinson's, showing promising trends and nominal significance in key analyses. 
Via Benzinga
Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Earnings Preview For Prothena Corp
 
Via Benzinga
Breaking Down Prothena Corp: 4 Analysts Share Their Views
 
Via Benzinga
Demystifying Prothena Corp: Insights From 8 Analyst Reviews
 
Via Benzinga
Decoding 6 Analyst Evaluations For Prothena Corp
 
Via Benzinga
Prothena Corp: Q4 Earnings Insights
 
Via Benzinga
Earnings Scheduled For May 8, 2025
 
Via Benzinga
A Look Ahead: Prothena Corp's Earnings Forecast
 
Via Benzinga
CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga
Prothena Corp Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
 
Via Benzinga
Earnings Scheduled For February 20, 2025
 
Via Benzinga
Deep Dive Into Prothena Corp Stock: Analyst Perspectives (5 Ratings)
 
Via Benzinga
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Demystifying Prothena Corp: Insights From 6 Analyst Reviews
 
Via Benzinga
Expert Ratings For Prothena Corp
 
Via Benzinga
Earnings Scheduled For November 12, 2024
 
Via Benzinga
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
Dow Dips 300 Points; Emcore Shares Spike Higher
 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Crude Oil Moves Higher; Prime Medicine Shares Spike Higher
 
Via Benzinga
Earnings Scheduled For February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. 
Via Benzinga
Earnings Outlook For Prothena Corp
 
Via Benzinga
PRTA Stock Earnings: Prothena Corp Beats EPS, Beats Revenue for Q2 2024
PRTA stock results show that Prothena Corp beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
An FDA panel unanimously backed Eli Lilly's Alzheimer's drug, but shares of Lilly and its rivals fell Tuesday. 
Via Investor's Business Daily
PRTA Stock Earnings: Prothena Corp Misses EPS, Misses Revenue for Q1 2024
PRTA stock results show that Prothena Corp missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.